Literature DB >> 14671083

Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors.

Florian Kreppel1, Stefan Kochanek.   

Abstract

High-capacity "gutless" adenovirus vectors (HC-AdV) mediate long-term transgene expression in resting cells in vitro and in vivo because of low toxicity and immunogenicity. However, in proliferating cells, expression is transient since HC-AdV genomes do not possess elements that allow for replication and segregation of the replicated genomes to daughter cells. We developed a binary HC-AdV system that, under certain conditions, allows for significantly prolonged episomal maintenance of HC-AdV genomes in proliferating tissue culture cells, resulting in sustained transgene expression. After transduction of target cells the linear HC-AdV genomes were circularized by the DNA recombinase FLPe, which was expressed from the second HC-AdV. The oriP/EBNA-1 replication system derived from Epstein-Barr virus, as well as the human replication origin from the lamin B2 locus, were used as cis elements to test for replication of the 28-kb circular vector genomes with or without selective pressure. Depending on the system, up to 98% of the circularized genomes were replicated and segregated to daughter cells, as demonstrated by Southern assays and as confirmed by monitoring EGFP transgene expression. Surprisingly, in the absence of FLPe recombinase, a small but significant number of HC-AdV genomes spontaneously circularized after transduction of target cells. These circles, found to contain end-to-end joined adenovirus termini, replicated with increased efficiency compared to vectors circularized by FLPe. After further improvements, this HC-AdV system might be suitable for gene therapy applications requiring long-term transgene expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14671083      PMCID: PMC303378          DOI: 10.1128/jvi.78.1.9-22.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.

Authors:  E R Leight; B Sugden
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations.

Authors:  Florian Kreppel; Volker Biermann; Stefan Kochanek; Gudrun Schiedner
Journal:  Hum Gene Ther       Date:  2002-07-01       Impact factor: 5.695

3.  Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.

Authors:  J L Yates; N Guan
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Isolation of human sequences that replicate autonomously in human cells.

Authors:  P J Krysan; S B Haase; M P Calos
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

5.  A circula DNA-protein complex from adenoviruses.

Authors:  A J Robinson; H B Younghusband; A J Bellett
Journal:  Virology       Date:  1973-11       Impact factor: 3.616

6.  Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector.

Authors:  Florian Kreppel; Thomas T Luther; Irina Semkova; Ulrich Schraermeyer; Stefan Kochanek
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

7.  Stabilization of transgenes delivered by recombinant adenovirus vectors through extrachromosomal replication.

Authors:  V A Krougliak; N Krougliak; R C Eisensmith
Journal:  J Gene Med       Date:  2001 Jan-Feb       Impact factor: 4.565

8.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

9.  Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication.

Authors:  Zhong Deng; Larissa Lezina; Chi-Ju Chen; Svetlana Shtivelband; Wingkan So; Paul M Lieberman
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

10.  Covalently closed circles of adenovirus 5 DNA.

Authors:  M Ruben; S Bacchetti; F Graham
Journal:  Nature       Date:  1983-01-13       Impact factor: 49.962

View more
  25 in total

Review 1.  Cocaine hydrolase gene therapy for cocaine abuse.

Authors:  Stephen Brimijoin; Yang Gao
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 2.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

Review 3.  Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems.

Authors:  Sabine Boeckle; Ernst Wagner
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

4.  A rapid protocol for construction and production of high-capacity adenoviral vectors.

Authors:  Lorenz Jager; Martin A Hausl; Christina Rauschhuber; Nicola M Wolf; Mark A Kay; Anja Ehrhardt
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

5.  Robust in vivo transduction of a genetically stable Epstein-Barr virus episome to hepatocytes in mice by a hybrid viral vector.

Authors:  Sean D Gallaher; Jose S Gil; Oliver Dorigo; Arnold J Berk
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

6.  Nanomedicine for gene therapy.

Authors:  Susan Muthe Alex; Chandra P Sharma
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

7.  Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.

Authors:  Maria Carolina N Marchetto; Alysson R Muotri; Dennis K Burns; Errol C Friedberg; Carlos F M Menck
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-14       Impact factor: 11.205

Review 8.  Helper-dependent adenoviral vectors in experimental gene therapy.

Authors:  Alicja Józkowicz; Józef Dulak
Journal:  Acta Biochim Pol       Date:  2005-08-04       Impact factor: 2.149

9.  Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

Authors:  Anurag Sharma; Dinesh S Bangari; Manish Tandon; Aseem Pandey; Harm HogenEsch; Suresh K Mittal
Journal:  Virology       Date:  2009-02-10       Impact factor: 3.616

10.  Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy.

Authors:  Hitoshi Suzuki; Norihiko Matsumoto; Tomoyuki Suzuki; Myint Oo Chang; Hiroshi Takaku
Journal:  Virol J       Date:  2009-10-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.